Skip to content
Chat on WhatsApp
Cagrilintide

Incretin-Pathway Peptides

Cagrilintide

An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.

  • Acylated amylin analogue
  • Acetate-form molecular weight stated
  • Sealed vials, 5mg to 20mg

Research use only

Cagrilintide is an acylated analogue of amylin, modified for extended activity relative to the native peptide. It sits in the incretin-pathway section of this catalog alongside other long-acting peptide analogues.

Research applications for material of this kind include amylin-receptor pharmacology studies, peptide stability assessment, structural analysis, and use as a reference standard in analytical workflows. The molecular weight shown on this page refers to the acetate form; salt form and lot-specific detail are set out in batch documentation.

Vials are sealed after freeze-drying and available at the nominal masses listed under available sizes, from 5mg through 20mg.

Purity≥99% by HPLC
CAS number1415456-99-3
Molecular weight4409 g/mol (acetate)
Molecular formulaC194H312N54O59S2
Material classModified peptide analogue
AppearanceWhite to off-white lyophilized powder
Available vial sizes5mg · 10mg · 20mg
DocumentationBatch documentation confirmed on request

← Back to the catalog